Physician profile
Cornelia Graves
NPI 1841202652
$504.07
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $14.46 · 2021: $22.71 · 2022: $22.36 · 2023: $76.04 · 2024: $54.35 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $127.06 | 2019 | |
| Daiichi Sankyo INC. | $111.54 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $74.66 | 2023-2024 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $57.05 | 2023-2025 | Vpriv |
| Dexcom, INC. | $34.92 | 2025 | Dexcom G6 Transmitter |
| Surgenex LLC | $34.65 | 2025 | Renograft, Ardeograft, Surgraft |
| Insulet Corporation | $23.89 | 2023 | Omnipod |
| Organon LLC | $22.36 | 2022 | |
| Octapharma USA, INC. | $17.94 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornelia Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.